New Knowledge Applied to Old Problems

Description

This session will take a contemporary look at arrhythmia treatments in pediatric and ACHD, the conduction system and lesser known preexcitation syndromes, and mechanisms of arrhythmia induced dysfunction.

Learning Objectives

Summarize recently developed molecules and re-purposed medications for treating arrhythmias.
Describe the conduction system and its development, including atypical forms of ventricular pre-excitation.
Review current understanding of the development of arrhythmia induced cardiac dysfunction.

Session Chair(s)

Carolina Escudero, MD, MS
Gregory Webster, MD, MPH

Presentation

New targets for Medications and Molecules in EP
Presenter(s): Dan M. Roden, MD

The Cardiac Conduction System at Single-cell Resolution: New Insights into Development and Disease
Presenter(s): William Rowland. Goodyer, MD, PhD

When the Wolff is Not the Villain: Atypical and Pseudo-Preexcitation
Presenter(s): Mary C. Niu, MD, MS

Cytoskeletons in the Closet: Tachycardia Induced Cardiomyopathy
Presenter(s): Sakethram Saravu Vijayashankar, MBBS, MD

Disclosures

Dan Roden:

Nothing Relevant to Disclose

William Goodyer:

Nothing Relevant to Disclose

Mary Niu:

Nothing Relevant to Disclose

Sakethram Saravu Vijayashankar:

Nothing Relevant to Disclose

To view all Heart Rhythm 2025 Faculty Disclosures, please click here.

Education Framework

General Concepts
   --   Pathophysiological Basis of Cardiac Arrhythmias and Basic EP
      --   1. Know normal cardiac anatomy, including the anatomy of the conduction system.

General Concepts
   --   Pathophysiological Basis of Cardiac Arrhythmias and Basic EP
      --   6. Know the mechanisms of cardiac arrhythmias including re-entry, triggered activity, and abnormal automaticity, as well as associated triggers such as ischemia, changes in autonomic tone, and drugs.

Summary


Availability:	No future session


Cost:	FREE


Credit Offered:	No Credit Offered